CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-01-10 | JACOBS CINDY EVP, CMO | Shares withheld for taxes | −3,369 | $0.63 | $2K | 84,359 |
| 2017-01-10 | JACOBS CINDY EVP, CMO | Option exercise · Restricted Stock Unit (RSU) | −2,500 | 0 | ||
| 2017-01-10 | JACOBS CINDY EVP, CMO | Option exercise · Restricted Stock Unit (RSU) | −3,125 | 3,125 | ||
| 2017-01-10 | JACOBS CINDY EVP, CMO | Option exercise · Restricted Stock Unit (RSU) | −4,687 | 9,375 | ||
| 2017-01-10 | Bencich John CFO | Option exercise | +3,125 | 12,609 | ||
| 2017-01-10 | Bencich John CFO | Shares withheld for taxes | −1,021 | $0.63 | $643 | 11,588 |
| 2017-01-10 | Bencich John CFO | Option exercise · Restricted Stock Unit (RSU) | −3,125 | 6,250 | ||
| 2017-01-10 | Cormack Scott Daniel President and CEO | Option exercise | +20,312 | 149,740 | ||
| 2017-01-10 | Cormack Scott Daniel President and CEO | Shares withheld for taxes | −9,690 | $0.63 | $6K | 140,050 |
| 2017-01-10 | Cormack Scott Daniel President and CEO | Option exercise | +10,312 | 84,055 | ||
| 2017-01-10 | Cormack Scott Daniel President and CEO | Option exercise · Restricted Stock Unit (RSU) | −4,687 | 0 | ||
| 2017-01-10 | Cormack Scott Daniel President and CEO | Option exercise · Restricted Stock Unit (RSU) | −6,250 | 6,250 | ||
| 2017-01-10 | Cormack Scott Daniel President and CEO | Option exercise · Restricted Stock Unit (RSU) | −9,375 | 18,750 | ||
| 2017-01-10 | Cormack Scott Daniel President and CEO | Option exercise · Restricted Stock Unit | −2,500 | 0 | ||
| 2016-08-19 | Bencich John CFO | Option exercise | +5,000 | 5,000 | ||
| 2016-08-19 | Bencich John CFO | Sale | −1,380 | $0.57 | $787 | 9,484 |
| 2016-08-19 | Bencich John CFO | Option exercise · Restricted Stock Unit (RSU) | −5,000 | 10,000 | ||
| 2016-06-13 | JACOBS CINDY EVP, CMO | Option exercise | +5,000 | 78,853 | ||
| 2016-06-13 | JACOBS CINDY EVP, CMO | Sale | −1,437 | $1.03 | $1K | 77,416 |
| 2016-06-13 | JACOBS CINDY EVP, CMO | Option exercise · Restricted Stock Unit (RSU) | −5,000 | 10,000 |
Page 21 of 36 · 715 trades